Octagon Therapeutics, Inc. in Massachusetts

Octagon Therapeutics, Inc. has 2 H-1B filings in Massachusetts with $76,231 avg salary. 100% approval rate.

In Massachusetts, Octagon Therapeutics, Inc. has sponsored 2 H-1B positions at an average compensation of $76k. The most common roles are Research Manager (Research Assistant) (100%). 100% of petitions were certified, with an average processing time of 9 days. 100% of positions are for new employment.

2
Filings
$76k
Avg Salary
100%
Approval Rate

Salary Statistics

Total Filings2
Approval Rate100%
Average Salary$76,231
Median Salary$76,231
25th Percentile$76,231
75th Percentile$76,231
Minimum Salary$76,231
Maximum Salary$76,231

Prevailing Wage Analysis

100% of filings offer salaries above the prevailing wage, with an average premium of 6.6%. The average prevailing wage is $71k (based on 2 filings with prevailing wage data).

Processing Time

Average processing time is 9 days (median: 10 days). Fastest: 7 days, slowest: 10 days. Based on 2 filings.

Workforce Insights

100% of filings are for new positions, while 0% are for continued employment (2 filings with data).

Average contract duration: 36 months (median: 36 months), based on 2 filings.

Education Requirements

Education LevelFilings
Not Specified2

Top Job Titles

Job TitleFilings
Research Manager (Research Assistant)2

Recent Filings

Frequently Asked Questions

How many H-1B jobs does Octagon Therapeutics, Inc. have in Massachusetts?

Octagon Therapeutics, Inc. has 2 H-1B filings in Massachusetts in our database of DOL public records.

What is Octagon Therapeutics, Inc.'s average salary in Massachusetts?

The average H-1B salary at Octagon Therapeutics, Inc. in Massachusetts is $76,231, with a median of $76,231. Salaries range from $76,231 to $76,231.

What is Octagon Therapeutics, Inc.'s H-1B approval rate in Massachusetts?

Octagon Therapeutics, Inc.'s H-1B approval rate in Massachusetts is 100% based on 2 DOL filings.

Octagon Therapeutics, Inc. Jobs in Massachusetts

Explore More

Immigration Guides